Literature DB >> 401721

Fosfomycin, antimicrobial activity in vitro and in vivo.

S Goto.   

Abstract

Antibacterial activities of fosfomycin were investigated both in vitro and in vivo for the purpose of comparative evaluation on its fundamental properties with other antimicrobial agents. The MIC was determined with nutrient agar (Difco) inoculated with one loopful of 1,000-fold dilution (about 10(6) cells/ml) of bacterial suspension cultured overnight in nutrient broth. This substance showed antibacterial activity to most gram-positive and gram-negative bacteria, being strongest to Enterobacteriaceae with a peak of the MIC at 1.56 mug/ml in Salmonella. It was also active against P. aeruginosa with a peak of the MIC at 6.25 mug/ml in its sensitivity distribution. Intravenous and subcutaneous fosfomycin Na salt and oral fosfomycin Ca salt were given to 5-week-old ddN strain male mice challenged with clinical isolates of P. aeruginosa, E. coli and P. mirabilis. Therapeutic effect was observed in all these test organisms. In P. aeruginosa, it was more effective than carbenicillin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 401721     DOI: 10.1159/000222028

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  8 in total

Review 1.  A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates.

Authors:  Friederike Traunmüller; Martin Popovic; Karl-Heinz Konz; Patrick Vavken; Andreas Leithner; Christian Joukhadar
Journal:  Clin Pharmacokinet       Date:  2011-08       Impact factor: 6.447

2.  Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in mice.

Authors:  T Matsumoto; K Tateda; S Miyazaki; N Furuya; A Ohno; Y Ishii; Y Hirakata; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

3.  Fosfomycin trometamol: activity in vitro against urinary tract pathogens.

Authors:  D Greenwood
Journal:  Infection       Date:  1990       Impact factor: 3.553

4.  In vitro investigations with fosfomycin on Mueller-Hinton agar with and without glucose-6-phosphate.

Authors:  H Grimm
Journal:  Infection       Date:  1979       Impact factor: 3.553

5.  [In vitro effect of fosfomycin against Pseudomonas aeruginosa compared to carbenicillin, gentamycin and polymyxin B].

Authors:  R Ansorg
Journal:  Infection       Date:  1978       Impact factor: 3.553

6.  The comparative activity of fosfomycin trometamol against organisms isolated from infected urines.

Authors:  D Greenwood; R Edwards; J Brown; P Ridout
Journal:  Infection       Date:  1992       Impact factor: 3.553

7.  Fosfomycin kinetics after intravenous and oral administration to human volunteers.

Authors:  M Goto; M Sugiyama; S Nakajima; H Yamashina
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

8.  Fosfomycin-ampicillin versus gentamicin-ampicillin in the treatment of critically ill patients with pneumonia.

Authors:  L R Nissen; J Jacobsen; T J Ravn; C Wahlgreen; H Auning-Hansen
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.